For example, a mutational SHP2 inhibitor, SHP099, reportedly inhibits tumor proliferation and migration in gastric cancer by dephosphorylating pyruvate kinase M2 (PKM2) protein [38]. The gene discussed is PTPN11; the disease is gastric cancer.